Hangzhou coben pharmaceutical co.,ltd.

About Hangzhou coben pharmaceutical co.,ltd.

Founded in 1997, Coben Group was designed and built according to GMP standard. It is located in specialized chemical zone——Zhejiang Nanyang and Jiangsu Qidong with a total area of 110,000M2. Coben is specialized in developing and manufacturing of APIs and intermediates for anti-AIDS drugs, anti-cancer drugs, cardiovascular drugs, anti-inflammatory drugs, and advanced intermediates.

Our main products include: Lamivudine, Tenofovir,Zidovudine, Abacavir, Emtricitabine, Losartan, Valsartan, Irbesartan, Eporlosartan, Clopidogrel, Gemcitabine,Carvedilol, Capecitabine, Loxoprofen, Etodolac, Tamsulosin and their intermediates. For cytosine, our annual output reaches 500MT, which is the largest among the world.

Coben is one of the state hi-tech enterprises and provincial hi-tech enterprises, owning provincial R&D center. Most of the products are self-developed. We hold national and international patents for many product. Our factory is full equipped, including more than three hundred 500-5000L glass-lined and stainless steel reactors, with a total capacity of 6...

  • CN
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
Contact info

Products from Hangzhou coben pharmaceutical co.,ltd. (3)

  • Adenine

    Product Adenine

    Active Pharmaceutical Ingredients
  • BCFI

    Product BCFI

    Cardiovascular System Drugs
  • Capecitabine